Pharsight

1. Drug name - NITHIODOTE

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8496973	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Mar, 2031 (8 years from now)
US9345724	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Mar, 2031 (8 years from now)
US9585912	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Mar, 2031 (8 years from now)
US8568793	HOPE PHARMS	Sodium nitrite-containing pharmaceutical compositions	Dec, 2031 (9 years from now)
EP3569237A1	HOPE PHARMS	Sodium Nitrite-Containing Pharmaceutical Compositions	Feb, 2030 (7 years from now)
EP3569237B1	HOPE PHARMS	Sodium Nitrite-Containing Pharmaceutical Compositions	Feb, 2030 (7 years from now)
EP2395834B1	HOPE PHARMS	Sodium Nitrite-Containing Pharmaceutical Compositions	Feb, 2030 (7 years from now)
EP2395834A1	HOPE PHARMS	Sodium Nitrite-Containing Pharmaceutical Compositions	Feb, 2030 (7 years from now)
EP2395834A4	HOPE PHARMS	Sodium Nitrite-Containing Pharmaceutical Compositions	Feb, 2030 (7 years from now)
EP2451435B1	HOPE PHARMS	Sodium Thiosulfate-Containing Pharmaceutical Compositions	Jul, 2030 (7 years from now)
EP2451435A4	HOPE PHARMS	Sodium Thiosulfate-Containing Pharmaceutical Compositions	Jul, 2030 (7 years from now)
EP2451435A1	HOPE PHARMS	Sodium Thiosulfate-Containing Pharmaceutical Compositions	Jul, 2030 (7 years from now)
EP2451435B2	HOPE PHARMS	Sodium Thiosulfate-Containing Pharmaceutical Compositions	Jul, 2030 (7 years from now)

Treatment: NA

Dosage: SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS

Strength	Dosage	Availability
300MG/10ML(30MG/ML),N/A;N/A,12.5GM/50ML(250MG/ML)	SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS	Prescription

availability in other generic markets.

Click on the highlighted region to filter.